Task: Please answer the following question about the molecule with SMILES Nc1cc(N2CCCCC2)nc(N)[n+]1[O-].
Question: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Completion: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]
Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]
3-oxidanidyl-6-piperidin-1-yl-pyrimidin-3-ium-2,4-diamine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.